Please login to the form below

Not currently logged in
Email:
Password:

VCLS appoints Carole Jones to senior market access role

She joins from Envision Pharma Group

Carole JonesGlobal product development consultancy Voisin Consulting Life Sciences (VCLS) has appointed Carole Jones as its Diretor of Market Access in a role that will see her focus on expanding the company’s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support.

She said: “I am delighted to be part of an organisation with such an active focus on the integration of payer evidence requirements into clinical development programmes for our clients.

“The combination of world class regulatory and health economics expertise allows us to be powerful advocates for our clients in navigating the complex, evolving pharmaceutical environment.

“The goal of delivering innovative therapies and making them accessible to patients is at the forefront of the company’s and my own vision.”

Jones previously worked for a variety of biotech, pharma and service companies including Novlion Therapeutics (formerly QLT), QuintilesIMS (formerly IMS Health) and Envision Pharma Group, where she was involved in publication strategy, development of manuscripts and white papers for peer-reviewed journals, systematic literature reviews, global value dossiers and interactive field-based assets.

Emmanuelle Voisin, founder and CEO of VCLS, said: “We at VCLS are excited about the appointment of Carole Jones and the opportunities it will bring.

“The extensive experience Carole brings will strengthen our capabilities and put us at the forefront of integrated pharmaceutical development strategy.”

23rd May 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

R&D protocol amendments
Rethinking trials: the pros and cons of protocol amendments
Protocol amendments occur often and can be beneficial, but the steps involved can be complex...
Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...

Infographics